309 related articles for article (PubMed ID: 12858452)
41. Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Asano Y; Kadono T; Sato S
J Rheumatol; 2011 Oct; 38(10):2193-7. PubMed ID: 21807780
[TBL] [Abstract][Full Text] [Related]
42. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
[TBL] [Abstract][Full Text] [Related]
43. Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis.
Olszyna DP; Opal SM; Prins JM; Horn DL; Speelman P; van Deventer SJ; van der Poll T
J Infect Dis; 2000 Dec; 182(6):1731-7. PubMed ID: 11069246
[TBL] [Abstract][Full Text] [Related]
44. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
45. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
46. Increased serum soluble CD40 levels in patients with systemic sclerosis.
Komura K; Fujimoto M; Matsushita T; Yanaba K; Kodera M; Kawasuji A; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2007 Feb; 34(2):353-8. PubMed ID: 17295440
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
[TBL] [Abstract][Full Text] [Related]
48. Circulating growth-regulator oncogene alpha contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease.
Brandt E; Müller-Alouf H; Desreumaux P; Woerly G; Colombel JF; Capron M
Eur Cytokine Netw; 1998 Dec; 9(4):647-53. PubMed ID: 9889409
[TBL] [Abstract][Full Text] [Related]
49. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
[TBL] [Abstract][Full Text] [Related]
50. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.
Del Rosso A; Distler O; Milia AF; Emanueli C; Ibba-Manneschi L; Guiducci S; Conforti ML; Generini S; Pignone A; Gay S; Madeddu P; Matucci-Cerinic M
Ann Rheum Dis; 2005 Mar; 64(3):382-7. PubMed ID: 15708892
[TBL] [Abstract][Full Text] [Related]
51. Circulating concentrations of chemokines in cord blood, neonates, and adults.
Sullivan SE; Staba SL; Gersting JA; Hutson AD; Theriaque D; Christensen RD; Calhoun DA
Pediatr Res; 2002 May; 51(5):653-7. PubMed ID: 11978892
[TBL] [Abstract][Full Text] [Related]
52. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
[TBL] [Abstract][Full Text] [Related]
53. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
Kim WU; Min SY; Cho ML; Hong KH; Shin YJ; Park SH; Cho CS
Arthritis Res Ther; 2005; 7(1):R71-9. PubMed ID: 15642145
[TBL] [Abstract][Full Text] [Related]
54. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
[TBL] [Abstract][Full Text] [Related]
55. Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects.
Jinquan T; Møller B; Storgaard M; Mukaida N; Bonde J; Grunnet N; Black FT; Larsen CG; Matsushima K; Thestrup-Pedersen K
J Immunol; 1997 Jan; 158(1):475-84. PubMed ID: 8977225
[TBL] [Abstract][Full Text] [Related]
56. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation.
Mellembakken JR; Solum NO; Ueland T; Videm V; Aukrust P
Thromb Haemost; 2001 Nov; 86(5):1272-6. PubMed ID: 11816717
[TBL] [Abstract][Full Text] [Related]
57. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
[TBL] [Abstract][Full Text] [Related]
58. Levels of the chemokines growth-related oncogene alpha and epithelial neutrophil-activating protein 78 are raised in patients with severe acute pancreatitis.
Shokuhi S; Bhatia M; Christmas S; Sutton R; Neoptolemos JP; Slavin J
Br J Surg; 2002 May; 89(5):566-72. PubMed ID: 11972545
[TBL] [Abstract][Full Text] [Related]
59. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
[TBL] [Abstract][Full Text] [Related]
60. [Interleukin-2 and interleukin-6 in serum as markers of disease progression in systemic sclerosis].
Lis A; Brzezińska-Wcisło L
Pol Merkur Lekarski; 2001 Sep; 11(63):206-9. PubMed ID: 11761811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
